Betamethasone/calcipotriol - 3SBioAlternative Names: Calcipotriene/betamethasone - 3SBio
Latest Information Update: 28 Jan 2016
At a glance
- Originator 3SBio
- Class Anti-inflammatories; Antipsoriatics; Cyclohexenes; Dihydroxycholecalciferols; Fluorinated steroids; Glucocorticoids; Indenes; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists; Steroid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Plaque psoriasis
Most Recent Events
- 27 Jan 2016 Preclinical trials in Plaque psoriasis in China (unspecified route)